sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing | GST - Goods and Services Tax
Latest Expert Exchange
« Markets »
 FM calms nerves, says no plan to tax market gains
 Why we must tweak the market-led model
 PE transactions prompt income tax queries over round tripping concerns
 Amended India-Mauritius tax treaty only covers investments in shares
 Government drops cap gains tax on startup shares held for 2 years
 Tax-free bonds regain demand in the secondary market
 Relevant Market’ Under Competition Act, 2002
 Indian markets best in terms of earnings momentum, price revision
 How India will become a common market with GST
 Broader markets outperform; Nifty holds 8,500
 Have Indian markets run ahead of fundamentals?

Market rewards consistency
July, 27th 2009

Conversely, Ranbaxy Laboratories, Matrix Laboratories, Biocon, Aurobindo Pharma and Lupin have been the worst performers on the similar parameter. Most of these companies have seen significant volatility in their quarterly earnings.

Ranbaxy Laboratories have seen series of factors affecting its earnings chief among them are regulatory clamp-down affecting its business in US, forex losses due to currency volatility and poor performance in key markets.

Matrix Laboratories has been incurring intermittent losses in last two years due to restructuring exercise. Torrent Pharma and Dr Reddys Laboratories are other two companies with low risk-adjusted returns.

An interesting insight revealed through the analysis is the presence of companies like Lupin and Matrix Laboratories that have relatively high absolute returns but have very low risk-adjusted returns.

If one were to look at the historical market performance, companies with lesser earning volatility have given more consistent returns than the ones whose earnings has been unpredictable. For instance, Sun Pharma or Ciplas stock market performance has been more stable than say Ranbaxy or DRL (see the graph Win Some Lose Some).

Hence risk-averse investors should give priority to stability of earnings rather than higher but volatile earnings. Others, who love to take risk, should assign higher discount rates to the earnings of those companies appearing at the bottom of our list.

Finally, like any other analysis, one should remember that the above analysis represents one out of many aspects while taking an investment decisions and hence investors should look at a stock in totality.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2018 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
Customer relationship management software CRM software Operational CRM Collaborative CRM

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions